HL-089 Outcomes in Patients With New Diagnose of Hodgkin Disease: Real-World Data in Public Health Institution in Mexico Without Access to Anti-CD30 and PD-1 Checkpoint Inhibitors in First-Line Therapy

Autor:	Guillermo Sotomayor Duque, Yarezi Brislett Garcia Cerda, Jose Alfredo Carrizales Villarreal, Severiano Baltazar Arellano, José Luis Cedillo de la Cerda, Martha Lilia Guajardo Leal, Diego Gustavo Cruz Contreras, Helga Patricia Sorkee Dávila, Myrna Patricia Pequeño Luevano, Dora Carolina Aldama Gutierrez, Juan Daniel Garza Escobar, Victor Valerio Bugarin, Karen Michelle Machuca Adame, Luis Omar Gudiño Cobos, Dania Getsemani Contreras Martinez, Raul Sergio Campillo Gonzalez, Tania Beltran Nevárez, Roxana Saldaña Vazquez, Rosa Elva De León Cantu, Roberto Hernandez Valdes
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S344
ISSN:	2152-2650
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3e621c70b540efe39a9be16af13c138d https://doi.org/10.1016/s2152-2650(22)01472-0 Zobrazit plný text záznamu Full Text from ScienceDirect